Clinical Trials
2 trialsNCT04416516 2024-04-10
Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
Ascend Biopharmaceuticals Ltd
Phase 2 Completed
NCT03208296 2023-02-06
Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)
Ascend Biopharmaceuticals Ltd
Phase 1/2 Suspended